Februar 2014 - IOZK

Phase I dendritic cell p53 peptide vaccine for head and neck cancer

2014-02-28/in Dendritic Cells, International Publications

Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma

2014-02-27/in Dendritic Cells, International Publications, Malignant Melanoma

DNA fragmentation and caspase-independent programmed cell death by modulated electrohyperthermia

2014-02-22/in Hyperthermia, International Publications

Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response

2014-02-18/in Dendritic Cells, Glioblastoma, International Publications

Long-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates

2014-02-05/in Dendritic Cells, International Publications, Malignant Melanoma

Immunotherapy prospects in the treatment of lung cancer and mesothelioma

2014-02-01/in International Publications, Malignant Pleural Mesothelioma, NSCLC, SCLC

Fighting fire with fire: the revival of thermotherapy for gliomas

2014-02-01/in Glioblastoma, Hyperthermia, International Publications

Immunotherapy in lung cancer

2014-02-01/in International Publications, NSCLC, SCLC